New inotropic drugs for heart failure.
D000318:Adrenergic beta-Agonists / Q000627:therapeutic use; D000818:Animals; D002118:Calcium / Q000378:metabolism; D002316:Cardiotonic Agents / Q000627:therapeutic use*; D004298:Dopamine / Q000502:physiology; D006333:Heart Failure / Q000188:drug therapy*; D006801:Humans; D010726:Phosphodiesterase Inhibitors / Q000627:therapeutic use
D000318:Adrenergic beta-Agonists; D002316:Cardiotonic Agents; D010726:Phosphodiesterase Inhibitors; D002118:Calcium; D004298:Dopamine